Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB with ropivacaine versus placebo for pain after lumbar spinal fusion surgery
NL-OMON54322Phase 4Recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing ESPB with ropivacaine with Placebo ESPB with normal saline (2 arms). Primary endpoint: Pain intensity upon emergence from anesthesia. Started May 2022; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON54322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54322.